Showing 5641-5660 of 8668 for: Cochrane Systematic Reviews Back
- Over the counter (OTC) artificial tear drops for dry eye syndrome
Cochrane Systematic Reviews, 23-Feb-2016
Over the counter (OTC) artificial tears historically have been the first line of treatment for dry eye syndrome and dry eye-related conditions like contact lens discomfort, yet currently we know little regarding the overall efficacy of individual, commerc
- Overground physical therapy gait training for chronic stroke patients with mobility deficits
Cochrane Systematic Reviews, 8-Jul-2009
Overground gait training forms a major part of physical therapy services for chronic stroke patients in almost every setting. Overground gait training refers to physical therapists' observation and cueing of the patient's walking pattern along with relate
- Over‐the‐counter (OTC) medications for acute cough in children and adults in community settings
Cochrane Systematic Reviews, 24-Nov-2014
Acute cough due to upper respiratory tract infection (URTI) is a common symptom. Non-prescription, over-the-counter (OTC) medicines are frequently recommended as a first-line treatment, but there is little evidence as to whether these drugs are effective.
- Over‐the‐counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
Cochrane Systematic Reviews, 10-Mar-2014
Cough is often distressing for patients with pneumonia. Accordingly they often use over-the-counter (OTC) cough medications (mucolytics or cough suppressants). These might provide relief in reducing cough severity, but suppression of the cough mechanism m
- Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome
Cochrane Systematic Reviews, 17-Jul-2008
The risks of multiple pregnancy and ovarian hyperstimulation syndrome (OHSS) are increased in women with clomiphene resistance WHO group 2 dysfunction undergoing ovulation induction as well as the risk of spontaneous abortion if conception takes place. Se
- Ovulation suppression for endometriosis for women with subfertility
Cochrane Systematic Reviews, 18-Jul-2007
Endometriosis is the presence of endometrial glands or stroma in sites other than the uterine cavity and appears to be an oestrogen-dependent condition. This dependency has prompted the therapeutic use of ovulation suppression agents in an effort to impro
- Ovulation triggers in anovulatory women undergoing ovulation induction
Cochrane Systematic Reviews, 31-Jan-2014
Anovulation is a common cause of infertility. Drugs used to treat anovulation include selective oestrogen receptor modulators, aromatase inhibitors and gonadotrophins. Ovulation triggers are used with these drugs, as a surrogate for the hormonal surge see
- Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome
Cochrane Systematic Reviews, 30-Oct-2019
The final adult height of untreated girls aged up to 18 years with Turner syndrome (TS) is approximately 20 cm shorter compared with healthy females. Treatment with growth hormone (GH) increases the adult height of people with TS. The effects of adding th
- Oxatomide for stable asthma in adults and children
Cochrane Systematic Reviews, 22-Apr-2003
Oxatomide is a histamine H1-receptor antagonist. As an oral agent, oxatomide may be useful in managing asthma. Some guidelines recommend oxatomide for long-term prophylaxis of asthma in children. There is no clear evidence whether children or adults with
- Oxcarbazepine add‐on for drug‐resistant focal epilepsy
Cochrane Systematic Reviews, 4-Mar-2020
Epilepsy is a common neurological disorder. In approximately 30% of epilepsy cases, seizures are uncontrolled by one antiepileptic drug (AED). These people require treatment with a combination of multiple AEDs and are described as having drug-resistant ep
- Oxcarbazepine add-on for drug-resistant partial epilepsy
Cochrane Systematic Reviews, 15-Nov-2016
Most people with epilepsy have a good prognosis and their seizures can be well controlled with the use of a single antiepileptic drug, but up to 30% develop refractory epilepsy, especially those with partial seizures. In this review we summarize the curre
- Oxcarbazepine for acute affective episodes in bipolar disorder
Cochrane Systematic Reviews, 9-Nov-2011
Oxcarbazepine, a keto derivative of the ‘mood stabiliser’ carbamazepine, may have efficacy in the treatment of acute episodes of bipolar disorder. Potentially, it may offer pharmacokinetic advantages over carbamazepine.
- Oxcarbazepine for neuropathic pain
Cochrane Systematic Reviews, 2-Dec-2017
Several anticonvulsant drugs are used in the management of neuropathic pain. Oxcarbazepine is an anticonvulsant drug closely related to carbamazepine. Oxcarbazepine has been reported to be efficacious in the treatment of neuropathic pain, but evidence fro
- Oxcarbazepine in the maintenance treatment of bipolar disorder
Cochrane Systematic Reviews, 23-Jan-2008
Some studies have suggested that oxcarbazepine has a role in preventing episode recurrence in bipolar affective disorder. This review attempted to investigate the existing evidence from randomised controlled trials for its use in the maintenance treatment
- Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures
Cochrane Systematic Reviews, 7-Oct-2009
Partial onset seizures are often treated with the standard antiepileptic drug carbamazepine. Oxcarbazepine is a newer antiepileptic drug related to carbamazepine that is claimed to be better tolerated.
- Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
Cochrane Systematic Reviews, 23-Oct-2018
This is an updated version of the Cochrane Review previously published in 2013. This review is one in a series of Cochrane Reviews investigating pair-wise monotherapy comparisons.
- Oximes for acute organophosphate pesticide poisoning
Cochrane Systematic Reviews, 16-Feb-2011
Acute organophosphorus pesticide poisoning causes tens of thousands of deaths each year across the developing world. Standard treatment involves administration of intravenous atropine and oxime to reactivate inhibited acetylcholinesterase. The clinical us
- Oxycodone for cancer‐related pain
Cochrane Systematic Reviews, 22-Aug-2017
Many people with cancer experience moderate to severe pain that requires treatment with strong opioids, such as oxycodone and morphine. Strong opioids are, however, not effective for pain in all people, neither are they well-tolerated by all people. The a
- Oxycodone for neuropathic pain in adults
Cochrane Systematic Reviews, 28-Jul-2016
This is an update of an earlier review that considered both neuropathic pain and fibromyalgia (Issue 6, 2014), which has now been split into separate reviews for the two conditions. This review considers neuropathic pain only.
- Oxycodone for pain in fibromyalgia in adults
Cochrane Systematic Reviews, 1-Sep-2016
This review replaces part of an earlier review that evaluated oxycodone for both neuropathic pain and fibromyalgia, which has now been split into separate reviews for the two conditions. This review will consider pain in fibromyalgia only.
